Methandriol diacetate

Methandriol Diacetate is a synthetic and injectable anabolic steroid that is used in the field of medicine to treat a variety of health conditions. It is a derivative of testosterone, which is the primary male sex hormone. Methandriol Diacetate is also known by its chemical name, 17α-methylandrost-5-ene-3β,17β-diol diacetate.

History

Methandriol Diacetate was first described in 1935 and was introduced for medical use in the 1950s. It was developed by the pharmaceutical company Organon, which is a global health leader that focuses on developing innovative and meaningful treatments.

Medical Uses

Methandriol Diacetate is used in the treatment of hypogonadism, a condition where the body does not produce enough testosterone. It is also used to treat certain types of breast cancer in women. In addition, it has been used to treat osteoporosis, a condition that weakens bones and makes them more prone to fractures.

Side Effects

Like all anabolic steroids, Methandriol Diacetate can have several side effects. These can include acne, hair loss, and gynecomastia. It can also have more serious side effects such as liver damage and cardiovascular disease.

Legal Status

In many countries, Methandriol Diacetate is classified as a controlled substance. This means that it is illegal to buy, sell, or possess without a valid prescription. In the United States, it is classified as a Schedule III controlled substance under the Controlled Substances Act.

See Also

• Anabolic steroid
• Testosterone
• Hypogonadism
• Breast cancer
• Osteoporosis